Search & fact check with cited sources for What is reported about Apple testing DRAM chips from China's state backed ChangXin Memory Technologies (CXMT) for devices sold in China, including the lobbying efforts Apple is leading to permit broader use of CXMT despite its Pentagon 1

2. Lobbying & Regulatory Hurdle

• CXMT was added to the Pentagon's Section 1260H "Chinese military company" list in June 2026 (alongside Alibaba, Baidu, BYD, and YMTC) . That designation restricts U.S. government contracts but is not a full trade ban.
• Apple has lobbied the White House, Commerce Department, and other parts of the Trump administration for formal assurance that buying from CXMT will not trigger later trade action, such as escalation to the Commerce Department's Entity List (which would impose a full export ban) .
• Apple is seeking a "green light" or waiver that would shield its supply arrangement even if U.S.-China tensions escalate further .

3. Global DRAM Shortage Context

• Memory contract prices have surged 55–60% driven by AI data center demand, directly pressuring Apple's hardware margins .
• On June 25, 2026, Apple raised Mac and iPad prices by 15–25%, citing memory and storage chip costs .
• Analyst Ming-Chi Kuo said the move is less about cost savings and more about "surviving a worsening AI-driven supply crunch," with the memory supply-demand gap expected to widen through 2027 .

4. CXMT's Market Position

• CXMT is the world's fourth-largest DRAM producer, behind Samsung, SK hynix, and Micron (who collectively hold >90% of the market) .
• Omdia data cited in CXMT's IPO prospectus shows CXMT's global DRAM share rose from ~4% in Q2 2025 to 7.67% in Q4 2025, and multiple sources report it reached ~8% in Q1 2026 .
• Some analysts project CXMT's share could reach 14% by 2027 .
• CXMT is pursuing a $4.2 billion Shanghai IPO to fund capacity expansion .
• The company swung from a net loss in early 2025 to ¥33 billion ($4.5B) net profit on ¥50.8B revenue in Q1 2026 — revenue up roughly 7x year-over-year .

5. Market Reaction

• Apple's stock rose 3.1% on Friday June 26 (the day the FT story broke) and another 0.4% in premarket on June 29 to ~$285 .
• Loop Capital reiterated a Buy rating, and multiple analysts noted the CXMT talks signal a genuine supply-access problem, not just a price play .
• On June 25, before the CXMT news, Apple shares had fallen 6.1% on the same day Samsung and SK hynix rallied on AI memory demand — the same memory-price surge that Apple was trying to mitigate .

6. Supply-Chain Reshaping Implications

• If approved, Apple's adoption of CXMT would be the largest validation of a Chinese DRAM maker by a Western consumer electronics giant, potentially unlocking massive volume for CXMT and accelerating its technology roadmap .
• The move would create a de facto China-specific memory supply chain for Apple devices sold there, parallel to its existing Samsung/SK hynix/Micron supply lines for the rest of the world .
• This could force competitors (HP, Dell, Lenovo — who already evaluate CXMT modules) to deepen their own China sourcing .
• The key risk: if Washington escalates CXMT to the Commerce Entity List, Apple would have to unwind the entire arrangement .
• The episode tests the limits of the U.S.-China trade truce and whether national security restrictions on Chinese chipmakers can coexist with commercial demand during a global shortage .

Note: The Pentagon's 1260H list is a designation that a company is a "Chinese military company" — it restricts U.S. government procurement but does not by itself impose a ban on private-sector purchases. The Commerce Department's Entity List is the far stricter regime. Apple is seeking assurances that CXMT will not be escalated to that level .